50岁及以上骨质疏松性髋部骨折患者住院费用的结构变化度分析

Structural Change Analysis of Hospitalization Expenses in Patients Aged 50 and Over with Osteoporotic Hip Fracture

目的 了解50岁及以上骨质疏松性髋部骨折患者住院费用现状及结构变化趋势,为调整费用结构及控制增速,缓解患者经济负担提供依据。方法 分析2010年1月1日-2021年12月31日收集的14 669例50岁及以上骨质疏松性髋部骨折住院费用的结构变动度情况。结果 2010-2021年整体例均住院费用为49945.00元,且呈逐年缓慢增长趋势,整体结构变动度为30.47%,其中2012-2013年结构变动度最大(9.42%)。材料费、药物费及检查费是结构变动的主要费用项目,材料费整体呈正向变动(结构变动值:12.29)、药物费及检查费呈负向变动(结构变动值:-8.99和-4.72),三者累计贡献率为85.31%。对例均住院总费用拉动力负值最高是药物费(-1.52),正值最高为材料费(1.58)。结论 住院费用整体缓慢增长,材料费是其升高的主要因素,药物费则是抑制住院费用快速增长的主要原因,表明医改已初见成效,但仍需继续合理控制医疗费用的增长。

Objectives This study aims to understand the current situation and structural change trend of hospitalization expenses for patients aged 50 and above with osteoporotic hip fracture, so as to provide a basis for adjusting the cost structure and controlling the growth rate and alleviating the economic burden of patients.Methods The structural variation of hospitalization expenses for osteoporotic hip fractures in 14 669 cases of osteoporotic hip fractures aged 50 and over collected from January 1, 2010 to December 31, 2021 was analyzed.Results From 2010 to 2021, the overall average hospitalization fee was 49 945.00 yuan, and it showed a slow growth trend year by year. The overall structure change degree was 30.47%, among which the structure change degree was the largest(9.42%) in 2012-2013. Material costs, drug costs, and inspection costs were the main cost items for structural changes. The overall material cost had a positive change(structural change value: 12.29), and the drug and inspection fee had a negative change(structural change value:-8.99 and-4.72), and the cumulative contribution rate of the three was 85.31%. The highest negative value of the driving force of the total hospitalization expenses per case was the cost of drugs(-1.52), and the highest positive value was the cost of materials(1.58).Conclusions Overall hospitalization costs are growing slowly. The cost of materials is the main factor for its increase,and the cost of drugs is the main reason for restraining the rapid growth of hospitalization costs, suggesting that the medical reform has achieved initial results, but the growth of medical expenses still needs to be reasonably controlled.